USPTO serial 97869600
INVEA
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- HINES, REGINA C
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with INVEA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan Harris
Jonathan Harris NUTTER, MCCLENNEN & FISH, LLP155 SEAPORT BOULEVARDSEAPORT WESTBOSTON, MA 02210Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; all these goods excluding food supplements, dietetic food preparations and ingredients and other dietetic products | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders and diseases relating to the gut-brain axis, involving the central nervous system, enteric nervous system, immune system, gastrointestinal tract, and dermatology; chemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis ; biological preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; Pharmaceutical preparations for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; Pharmaceutical preparations in the field of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; all these goods/services excluding food supplements, dietetic food preparations and ingredients and other dietetic products; the mark is used as a house mark for the goods identified in the instant application | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 12, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 12, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 12, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 13, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 13, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2025 | NOAC | CORRECTED NOA E-MAILED | — |
| Oct 28, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Oct 23, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Oct 14, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 16, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 19, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 19, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2025 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 14, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 11, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 11, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 19, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 19, 2024 | ALIE | ASSIGNED TO LIE | — |
| Apr 18, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2023 | NWAP | NEW APPLICATION ENTERED | — |